Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (91-100 of 380) with videos related to

Pageof 38
Sort By:
European Journal of Haematology|October 26, 2011
Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioningLuca Facchini, Rodrigo Martino, Angela Ferrari, et al.
Journal of Pain and Symptom Management|August 16, 2017
Is Early Palliative Care Feasible in Patients With Multiple Myeloma?Josep Porta-Sales, Maria Guerrero-Torrelles, Deborah Moreno-Alonso, et al.
American Journal of Hematology|October 28, 2011
Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcomeJosé Luis Piñana, Rodrigo Martino, Pere Barba, et al.
AIDS (London, England)|September 28, 2002
Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's diseaseJosep-María Ribera, José-Tomás Navarro, Albert Oriol, et al.
British Journal of Haematology|December 19, 2018
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphomaSimon Rule, Gordon Cook, Nigel H Russell, et al.
Haematologica|July 2, 2013
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working PartySilvia Montoto, Paolo Corradini, Martin Dreyling, et al.
Blood|March 22, 2003
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantationJose A Perez-Simon, Maria Diez-Campelo, Rodrigo Martino, et al.
Hematological Oncology|December 1, 2024
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I TrialAnna Sureda, Antonio Pinto, Hervé Ghesquières, et al.
Bone Marrow Transplantation|November 22, 2025
Neglected tropical diseases (NTDs) and related infections in hematopoietic cellular therapy (HCT) in adults and children: a survey from the Infectious Diseases Working Party (IDWP) of the European Society of Blood and Marrow Transplantation (EBMT)John A Snowden, Vivak Parkash, Nina Knelange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationRafael F Duarte, Carmen Canals, Francesco Onida, et al.
Pageof 38

Showing results (91-100 of 380) with videos related to

Sort By:
Pageof 38
European Journal of Haematology|October 26, 2011
Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioningLuca Facchini, Rodrigo Martino, Angela Ferrari, et al.
Journal of Pain and Symptom Management|August 16, 2017
Is Early Palliative Care Feasible in Patients With Multiple Myeloma?Josep Porta-Sales, Maria Guerrero-Torrelles, Deborah Moreno-Alonso, et al.
American Journal of Hematology|October 28, 2011
Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcomeJosé Luis Piñana, Rodrigo Martino, Pere Barba, et al.
AIDS (London, England)|September 28, 2002
Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's diseaseJosep-María Ribera, José-Tomás Navarro, Albert Oriol, et al.
British Journal of Haematology|December 19, 2018
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphomaSimon Rule, Gordon Cook, Nigel H Russell, et al.
Haematologica|July 2, 2013
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working PartySilvia Montoto, Paolo Corradini, Martin Dreyling, et al.
Blood|March 22, 2003
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantationJose A Perez-Simon, Maria Diez-Campelo, Rodrigo Martino, et al.
Hematological Oncology|December 1, 2024
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I TrialAnna Sureda, Antonio Pinto, Hervé Ghesquières, et al.
Bone Marrow Transplantation|November 22, 2025
Neglected tropical diseases (NTDs) and related infections in hematopoietic cellular therapy (HCT) in adults and children: a survey from the Infectious Diseases Working Party (IDWP) of the European Society of Blood and Marrow Transplantation (EBMT)John A Snowden, Vivak Parkash, Nina Knelange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationRafael F Duarte, Carmen Canals, Francesco Onida, et al.
Pageof 38